Evidence map›Paper›PMID 36211669›Full record

ArticleFrontiers in public health2022

Evaluation and driving factors of land use economic efficiency in China's urban agglomerations under the impact of COVID-19 epidemic.

Jianhua Wang, Junwei Ma

Abstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jianhua WangBusiness School, Changshu Institute of Technology, Suzhou, China.
Junwei MaBusiness School, Changshu Institute of Technology, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Land is an indispensable factor of production and the basic support for all social and economic activities. The COVID-19 epidemic has a great impact on China's macro-economy and land market. As a unit with a high concentration of economic entities, urban agglomeration is closely related to its land use economic efficiency. Under the impact of epidemic and the rigid constraints of the relative scarcity of land resources, improving the land use economic efficiency is crucial to the sustainable development of urban agglomerations. Taking the 10 major urban agglomerations in China as a case study, this paper constructs a theoretical and empirical analysis framework for the land use economic efficiency and its driving mechanism of urban agglomerations, and measures the land use economic efficiency of urban agglomerations from the aspects of single factor productivity and total factor productivity. The results show that the COVID-19 epidemic has a great impact on the land market of various cities in China's urban agglomerations. Whether single factor productivity or total factor productivity is used to measure land use economic efficiency of urban agglomerations, the driving effects of industrial agglomeration, industrial structure change, technological progress, and transportation infrastructure are all significant. It is necessary to take a series of measures to reform the market-oriented allocation of land elements, and improve a long-term mechanism for the smooth operation of the land market. It is necessary to improve the land use economic efficiency through a combination of industrial agglomeration, industrial structure adjustment, technological progress, and transportation infrastructure.

Indexed as

COVID-19EpidemicsChinaCitiesHumansIndustrydriving factorsefficiency evaluationland marketland use economic efficiencyurban agglomeration

Identifiers

PMID36211669
PMCPMC9538637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.